Effects of echinacoside on striatal extracellular levels of amino acidneurotransmitter in cerebral ischemia rats
Ming ZHONG,Hong CHEN,Yong JIANG,Peng-fei TU,Chun-li LIU,Wan-xin ZHANG,Jing-yi MA,Hui DING
DOI: https://doi.org/10.3969/j.issn.1001-1978.2012.03.015
2012-01-01
Abstract:Aim: To examine the effects of echinacoside (ECH) on striatal extracellular levels of ASP, Glu, Gly, GABA in cerebral ischemia rats and the rate of cerebral infarction and explore its possible mechanisms of neuro-protective effect. Methods: SD rats were divided into sham, model, positive control drug (CXQ 40 mg·kg -1) ECH high (ECH 40 mg·kg -1) and low dose (ECH 20 mg·kg -1) and HB groups (ECH 40 mg·kg -1, Borneo camphor 400 mg·kg -1) randomly. Every rat was administered drugs or vehicle through intraperitoneal injection, once a day for seven days. At the third day of administration, the probe tube was embedded in the striatum. 1 h after the last administration, focal ischemia was generated by permanent middle cerebral artery occlusion (MCAO). Then the striatal extracellular fluids were gained by brain microdialysis. The methods of high performance liquid chromatography with fluorescence detector were used to measure the striatal extracellular levels of Asp, Glu, Gly, and GABA. Results: Compared with the sham group, the levels of Asp, Glu, Gly, GABA were elevated. Compared with model group, ECH high dose group decreased the levels of Asp, Glu; effects on Gly and GABA of ECH low dose and ECH HB group were not obvious in statistics. Compared with model group, ECH high dose and ECH low dose groups significantly reduced the infarct area. Conclusion: ECH can reduce excitatory amino acids neurotransmitters of striatal extracellular levels, which may be one of the mechanisms of anti-cerebral ischemia.